» Articles » PMID: 17362578

The Clinical Significance of Immunoglobulin A Deficiency

Overview
Specialty Biochemistry
Date 2007 Mar 17
PMID 17362578
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

IgA deficiency is the most common primary immunoglobulin deficiency. The prevalence in Caucasians is around one in 500, whereas in some Asian populations it is very uncommon. Most individuals with IgA deficiency are clinically asymptomatic. Those with symptoms of immunodeficiency have predominantly sinopulmonary or gastrointestinal infections, which are more severe when associated with IgG2, IgG4 or specific antibody deficiency. IgA deficiency is believed to be one end of a spectrum of immunodeficiency with common variable immunodeficiency at the most severe end. Although primary IgA deficiency is the most commonly encountered form, secondary deficiencies due to drugs or viral infections are recognized. IgA deficiencies can be partial or transient. Primary IgA deficiency is caused by a defect of terminal lymphocyte differentiation, which leads to underproduction of serum and mucosal IgA; affected individuals have normal IgA genes. A number of non-immunoglobulin genes have been implicated in IgA deficiency. There have been many diseases reported in association with IgA deficiency, particularly autoimmune diseases. The most common association is with coeliac disease (CD), which has special significance since CD is usually diagnosed by detection of specific IgA antibodies that are obviously lacking in IgA deficiency. There is no specific treatment for patients with symptomatic IgA deficiency. Antibiotics are prescribed in those with acute infections. A significant proportion of IgA-deficient individuals are reported to have anti-IgA antibodies in their serum. Although blood or blood products given to IgA-deficient individuals can lead to severe, even fatal, transfusion reactions, such reactions are rare.

Citing Articles

IgG subclass levels in referred hemochromatosis probands with HFE p.C282Y/p.C282Y.

Barton J, Barton J, Bertoli L, Acton R PLoS One. 2024; 19(5):e0302817.

PMID: 38743659 PMC: 11093286. DOI: 10.1371/journal.pone.0302817.


Gene Signature of Regulatory T Cells Isolated from Children with Selective IgA Deficiency and Common Variable Immunodeficiency.

Rutkowska-Zapala M, Grabowska-Gurgul A, Lenart M, Szaflarska A, Kluczewska A, Mach-Tomalska M Cells. 2024; 13(5.

PMID: 38474381 PMC: 10930802. DOI: 10.3390/cells13050417.


IgG and IgM cooperate in coating of intestinal bacteria in IgA deficiency.

Eriksen C, Moll J, Myers P, Pinto A, Danneskiold-Samsoe N, Dehli R Nat Commun. 2023; 14(1):8124.

PMID: 38065985 PMC: 10709418. DOI: 10.1038/s41467-023-44007-2.


Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?.

Noto A, Cassin R, Mattiello V, Bortolotti M, Reda G, Barcellini W Front Immunol. 2023; 14:1062376.

PMID: 37122737 PMC: 10140292. DOI: 10.3389/fimmu.2023.1062376.


IGPred-HDnet: Prediction of Immunoglobulin Proteins Using Graphical Features and the Hierarchal Deep Learning-Based Approach.

Ali Z, Alturise F, Alkhalifah T, Khan Y Comput Intell Neurosci. 2023; 2023:2465414.

PMID: 36744119 PMC: 9891831. DOI: 10.1155/2023/2465414.